ChiCTR2200059642Not yet recruiting
Untitled Trial
Application research of artificial intelligence model in evaluating the prognosis of early lung cancer
Shanghai Pulmonary HospitalNot ApplicableChinese Clinical Trial Registry
Study focus
- Disease/Condition
- lung cancer
- Drug/Device/Intervention
- The first part: Improve and optimize the structure of the CT image 3D Res-Net prognosis model to verify the prediction accuracy; (1) Add the CT images of the public data Radiogenomics to sample and label the tumor area; (2) Improve and optimize the structure of 3D Res-Net, verify the accuracy of prognosis prediction, and compare with TNM staging; The second part: establishing a 2D MSD-Net model for tumor cell recognition in digital pathological images of lymph nodes; (1) Adding public data Camelyon16 lymph node digital pathological images and annotation information; (2) Establish and verify the 2D MSD-Net model of tumor cells in lymph node pathological images; The third part: Combine TL and MSD-Net, realize the feature extraction of tumor digital pathological tissue images, and establish and verify a comprehensive artificial intelligence prognosis model; (1) Combine TL and 2D MSD-Net to establish a feature extraction network for digital pathological images of tumor tissue; (2) Integrate clinical features, 3D Res-Net, and 2D MSD-Net to establish and verify an artificial intelligence prognosis evaluation model.
Sponsor & location
- Primary sponsor
- Shanghai Pulmonary Hospital
- Funder
- research funding
- Location
- China
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- N/A
- End date
- Dec 31, 2023
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200059642
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200059642 through Pure Global AI's free database. This Not Applicable trial is sponsored by Shanghai Pulmonary Hospital and is currently Not yet recruiting. The study focuses on lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.